ATORVASTATIN 80 MG TABLET
For 30 tablets
Pharmacies pay
$2.08 filed
30 × $0.06926 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$4.36 filed
30 × $0.14518 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.1× estimated
Medicare paid 2.1× what pharmacies pay.
Part D averages every strength and form sold under “Atorvastatin Calcium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$7.39 estimated
$2.08 + $0.31 (15%) + $5.00 fee per fill = $7.39
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ATORVASTATIN 80 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “atorvastatin calcium” and “atorvastatin calcium, film coated”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 26 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.
The NADAC file of 2026-10-14 prices it under 67 NDCs (National Drug Codes); the FDA directory lists 57 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.08 for 30 tablets (30 × $0.06926 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 26 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Dr. Reddy's Laboratories Inc | 7 | $0.06926 per EA filed |
| Laurus Labs Limited | 4 | $0.06926 per EA filed |
| NorthStar RxLLC | 4 | $0.06926 per EA filed |
| Camber Pharmaceuticals, Inc. | 3 | $0.06926 per EA filed |
| Macleods Pharmaceuticals Limited | 3 | $0.06926 per EA filed |
| Novadoz Pharmaceuticals LLC | 3 | $0.06926 per EA filed |
| Rising Pharma Holdings, Inc. | 3 | $0.06926 per EA filed |
| Apotex Corp. | 2 | $0.06926 per EA filed |
| Ascend Laboratories, LLC | 2 | $0.06926 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.06926 per EA filed |
| Biocon Pharma Inc. | 2 | $0.06926 per EA filed |
| Lifestar Pharma LLC | 2 | $0.06926 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.06926 per EA filed |
| NORTHSTAR RX LLC | 2 | $0.06926 per EA filed |
| ScieGen Pharmaceuticals, Inc. | 2 | $0.06926 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 2 | $0.06926 per EA filed |
| Teva Pharmaceuticals, Inc. | 2 | $0.06926 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 2 | $0.06926 per EA filed |
| American Health Packaging | 1 | $0.06926 per EA filed |
| AvPAK | 1 | $0.06926 per EA filed |
| Major Pharmaceuticals | 1 | $0.06926 per EA filed |
| Mylan Institutional Inc. | 1 | $0.06926 per EA filed |
| NIVAGEN PHARMACEUTICALS, INC. | 1 | $0.06926 per EA filed |
| Quallent | 1 | $0.06926 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.06926 per EA filed |
| Umedica Laboratories USA Inc. | 1 | $0.06926 per EA filed |
| Not listed as a package in the FDA directory | 10 | $0.06926 per EA filed |
When these prices took effect
- 2026-10-07 · 1 NDC · $0.06926 per EA filed
- 2026-09-30 · 2 NDCs · $0.06926 per EA filed
- 2026-09-23 · 64 NDCs · $0.06926 per EA filed
All 67 NDCs, with labeler and price
- 00093-5057-05 · Teva Pharmaceuticals USA, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00093-5057-98 · Teva Pharmaceuticals USA, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00378-3953-05 · Mylan Pharmaceuticals Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00378-3953-77 · Mylan Pharmaceuticals Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00480-3588-10 · Teva Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00480-3588-98 · Teva Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 00904-6293-04 · Major Pharmaceuticals · $0.06926 per EA · eff. 2026-09-23 filed
- 16571-0139-09 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 16571-0139-10 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 16571-0139-50 · Rising Pharma Holdings, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 16714-0176-01 · NORTHSTAR RX LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 16714-0176-03 · NORTHSTAR RX LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 31722-0427-05 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 31722-0427-10 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 31722-0427-90 · Camber Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 33342-0318-10 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 33342-0318-15 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 33342-0318-44 · Macleods Pharmaceuticals Limited · $0.06926 per EA · eff. 2026-09-30 filed
- 42385-0943-01 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 42385-0943-05 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 42385-0943-11 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 42385-0943-90 · Laurus Labs Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 42571-0175-10 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 42571-0175-90 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 43598-0103-05 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
- 43598-0103-87 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-30 filed
- 43598-0103-90 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
- 43598-0833-05 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
- 43598-0833-90 · Dr. Reddy's Laboratories Inc · $0.06926 per EA · eff. 2026-09-23 filed
- 50228-0454-05 · ScieGen Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 50228-0454-90 · ScieGen Pharmaceuticals, Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 50268-0096-11 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 50268-0096-12 · AvPAK · $0.06926 per EA · eff. 2026-09-23 filed
- 51079-0211-01 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 51079-0211-03 · Mylan Institutional Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 55111-0124-05 · Dr. Reddy's Laboratories Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 55111-0124-90 · Dr. Reddy's Laboratories Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 59651-0609-90 · Aurobindo Pharma Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 59651-0609-99 · Aurobindo Pharma Limited · $0.06926 per EA · eff. 2026-09-23 filed
- 60290-0042-04 · Umedica Laboratories USA Inc. · $0.06926 per EA · eff. 2026-10-07 filed
- 60505-2671-08 · Apotex Corp. · $0.06926 per EA · eff. 2026-09-23 filed
- 60505-2671-09 · Apotex Corp. · $0.06926 per EA · eff. 2026-09-23 filed
- 67877-0514-05 · Ascend Laboratories, LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 67877-0514-90 · Ascend Laboratories, LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 68084-0590-25 · American Health Packaging · $0.06926 per EA · eff. 2026-09-23 filed
- 68084-0590-95 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 68382-0252-10 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 68382-0252-16 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 70377-0030-12 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 70377-0030-14 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 70377-0080-11 · Biocon Pharma Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 70377-0080-13 · Biocon Pharma Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 70710-1770-00 · Zydus Pharmaceuticals USA Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 70710-1770-09 · Zydus Pharmaceuticals USA Inc. · $0.06926 per EA · eff. 2026-09-23 filed
- 70756-0250-51 · Lifestar Pharma LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 70756-0250-90 · Lifestar Pharma LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72205-0025-05 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72205-0025-90 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72205-0025-99 · Novadoz Pharmaceuticals LLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72603-0285-01 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72603-0285-02 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72603-0285-03 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
- 72603-0406-01 · not listed as a package in the FDA directory · $0.06926 per EA · eff. 2026-09-23 filed
- 72603-0406-02 · NorthStar RxLLC · $0.06926 per EA · eff. 2026-09-23 filed
- 75834-0258-01 · NIVAGEN PHARMACEUTICALS, INC. · $0.06926 per EA · eff. 2026-09-23 filed
- 82009-0004-10 · Quallent · $0.06926 per EA · eff. 2026-09-23 filed
- 82009-0179-10 · Quallent Pharmaceuticals Health LLC · $0.06926 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share an FDA nonproprietary name with ATORVASTATIN 80 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ATORVASTATIN 10 MG TABLET | $0.02283 per EA filed | $0.14518 per EA filed |
| ATORVASTATIN 20 MG TABLET | $0.02792 per EA filed | $0.14518 per EA filed |
| ATORVASTATIN 40 MG TABLET | $0.03743 per EA filed | $0.14518 per EA filed |
| ATORVASTATIN 80 MG TABLET this page | $0.06926 per EA filed | $0.14518 per EA filed |
| LIPITOR 10 MG TABLET | $13.40831 per EA filed | $15.7092 per EA filed |
| LIPITOR 20 MG TABLET | $19.07256 per EA filed | $15.7092 per EA filed |
| LIPITOR 40 MG TABLET | $19.11383 per EA filed | $15.7092 per EA filed |
| LIPITOR 80 MG TABLET | $19.00394 per EA filed | $15.7092 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 67 NDCs’ NADAC prices is $0.06926 per EA filed.
Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 40 have a higher middle NADAC price and 16 a lower one. The one in the middle is AMLODIPINE-ATORVAST 10-10 MG, at $0.97947 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $4.36 for 30 tablets, at an average of $0.14518 per EA in 2024 (2024-01-01 to 2024-12-31) for “Atorvastatin Calcium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 73,349,032 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ATORVASTATIN 80 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atorvastatin Calcium / Atorvastatin Calcium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- ROSUVASTATIN CALCIUM 10 MG TAB
- SIMVASTATIN 10 MG TABLET
- PRAVASTATIN SODIUM 10 MG TAB
- LOVASTATIN 10 MG TABLET
- EZETIMIBE-SIMVASTATIN 10-10 MG